PreveCeutical Medical Inc. is a health sciences company dedicated to developing innovative preventive and curative therapies by harnessing both nature and science. Founded in 2015 and headquartered in Vancouver, British Columbia, the company focuses on unmet clinical needs across diverse areas such as diabetes, obesity, pain management, neurological disorders, and cancer. It utilizes organic and nature-identical compounds to create treatments aimed at improving health outcomes, with notable research partnerships including the University of Queensland and institutes specializing in gene and peptide therapies. PreveCeutical advances novel therapeutic technologies like the Sol-Gel Cannabinoid Delivery system and non-addictive analgesics, reflecting its commitment to safer, effective health solutions. Its strategic activities encompass research, development, intellectual property securing, and commercialization efforts within the preventive health sector, aiming to deliver meaningful health benefits to consumers worldwide.